CardioMEMS Shows Promise for Expanded Use Despite Falling Short in Trial

By Kate Buron When The U.S. Food and Drug Administration (FDA) approved the CardioMEMS HF System in 2014, Abbott harnessed the power of artificial intelligence (AI) coupled with telemedicine for managing patients with heart failure (HF). Expanded use of the system was the objective of a new trial initiated in 2018, but the onset of […]

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.